作者：
Jessica S,Little [1]
;
Miranda S,Oakley [2]
;
Anna R,Thorner [1]
;
Demerise,Johnston [2]
;
Victoria,Majam [2]
;
Alexis D,Liakos [1]
;
Lewis A,Novack [3]
;
Hong,Zheng [2]
;
Scott,Meredith [2]
;
Chao-Kai,Chou [4]
;
Benjamin R,Newton [5]
;
Robert J,Soiffer [6]
;
Peter J,Krause [7]
;
Lindsey R,Baden [1]
;
Sanjai,Kumar [2]
作者单位：
Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.;Harvard Medical School, Boston, Massachusetts, USA.;Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
[1]
Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
[2]
Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.;Harvard Medical School, Boston, Massachusetts, USA.
[3]
Facility for Biotechnology Resources, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
[4]
Section of Medical Oncology, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
[5]
Harvard Medical School, Boston, Massachusetts, USA.;Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
[6]
Department of Epidemiology of Microbial Diseases, Yale School of Public Health and Yale School of Medicine, New Haven, Connecticut, USA.
[7]
DOI
10.1093/ofid/ofad568
PMID
38213635
发布时间
2024-10-23
换一批
换一批
